ArticleBiomedicines2024

Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability.

Marija Jovanović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.